Surveillance and Optimization of Antibiotics Usage

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".

Deadline for manuscript submissions: 15 May 2024 | Viewed by 2527

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacy Administration and Clinical Pharmacy, Peking University, Beijing, China
Interests: evidence-based pharmacy; therapeutic drug monitoring; clinical pharmacy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
Interests: pharmacoepidemiology; clinical epidemiology and evidence-based medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

From ancient quinine to the newly synthesized oxazolidinones, antibiotics have drastically changed human civilization and modern medicine in just over 100 years, widely prescribed in medical institutions across all departments, patients, and places of treatment. In community pharmacies, antibiotics are one of the most commonly prescribed drugs. The appropriateness of antibiotics is a global issue, mainly associated with factors such as antibacterial resistance evaluation, the rational choice of drugs, the optimization of drug usage and dosages, and the management of drug adverse reactions and costs.

Antibiotic use is strictly managed in hospitals, considering how widely they are used, the expenditure, and the serious consequences of antimicrobial abuse. Additionally, bacterial resistance surveillance systems are relatively well established, providing data for guidance on the appropriateness of antibiotics. Nevertheless, with the increasing complexity of clinical infections, the rational use of antibiotics still needs further research and improvement.

This Special Issue focuses on the appropriateness of antibiotic use, for which we invite scholars to report on the latest research and review results. This Special Issue also seeks manuscript submissions capable of further improving our understanding and experience surrounding rational antibiotic use.

Prof. Dr. Suodi Zhai
Prof. Dr. Siyan Zhan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • appropriateness of antibiotics
  • bacterial resistance
  • optimization of antibiotic usage and dosages
  • prescription
  • medical institutions
  • community pharmacies

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

13 pages, 614 KiB  
Perspective
Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward
by Mohammed Kanan, Maali Ramadan, Hanan Haif, Bashayr Abdullah, Jawaher Mubarak, Waad Ahmad, Shahad Mari, Samaher Hassan, Rawan Eid, Mohammed Hasan, Mohammed Qahl, Atheer Assiri, Munirah Sultan, Faisal Alrumaih and Areej Alenzi
Antibiotics 2023, 12(10), 1504; https://doi.org/10.3390/antibiotics12101504 - 02 Oct 2023
Cited by 4 | Viewed by 2248
Abstract
Antibiotic overuse poses a critical global health concern, especially in low- and middle-income countries (LMICs) where access to quality healthcare and effective regulatory frameworks often fall short. This issue necessitates a thorough examination of the factors contributing to antibiotic overuse in LMICs, including [...] Read more.
Antibiotic overuse poses a critical global health concern, especially in low- and middle-income countries (LMICs) where access to quality healthcare and effective regulatory frameworks often fall short. This issue necessitates a thorough examination of the factors contributing to antibiotic overuse in LMICs, including weak healthcare infrastructure, limited access to quality services, and deficiencies in diagnostic capabilities. To address these challenges, regulatory frameworks should be implemented to restrict non-prescription sales, and accessible point-of-care diagnostic tools must be emphasized. Furthermore, the establishment of effective stewardship programs, the expanded use of vaccines, and the promotion of health systems, hygiene, and sanitation are all crucial components in combating antibiotic overuse. A comprehensive approach that involves collaboration among healthcare professionals, policymakers, researchers, and educators is essential for success. Improving healthcare infrastructure, enhancing access to quality services, and strengthening diagnostic capabilities are paramount. Equally important are education and awareness initiatives to promote responsible antibiotic use, the implementation of regulatory measures, the wider utilization of vaccines, and international cooperation to tackle the challenges of antibiotic overuse in LMICs. Full article
(This article belongs to the Special Issue Surveillance and Optimization of Antibiotics Usage)
Show Figures

Figure 1

Back to TopTop